NCT04439344 2026-05-07Testing Binimetinib as a Potential Targeted Treatment in Cancers With NRAS Genetic Changes (MATCH-Subprotocol Z1A)National Cancer Institute (NCI)Phase 2 Active not recruiting53 enrolled 10 charts